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Multimodal analgesia is gaining popularity in veterinary medicine. It is an approach that 
involves the administration of two or three classes of analgesic drugs with different 
modes of actions to enhance the analgesic effects and lower the adverse effects 
associated with high dose of a single drug. In a series of experiments conducted in this 
thesis, the combinations of morphine, dexmedetomidine and maropitant were evaluated 
using different pain models with the aim of using them in a multimodal strategy in dogs 
undergoing ovariohysterectomy or other surgical procedures.  
Firstly, a pilot study evaluating the efficacy of combinations of the test drugs was 
performed using a hot-plate test and tail-flick test in rats. The combination of morphine 
and maropitant showed a significantly higher (p < 0.0001) tail-flick latency compared to 
all other treatment groups indicating a supra-additive effect of spinal analgesia between 
morphine and maropitant. 
A pharmacokinetic study to investigate the disposition of the test drug combinations 
after intramuscular (IM) administration in dogs under anaesthesia was conducted. The 
results showed that the elimination half-life of morphine was higher and the clearance 
rate was lower when combined with dexmedetomidine compared to morphine and 
maropitant combination or morphine alone at higher doses. This effect may have a 
clinical advantage of prolonging the dosing interval of morphine.  
A study to evaluate and compare the analgesic efficacy of the combination of morphine, 
dexmedetomidine and maropitant in dogs undergoing ovariohysterectomy was 
conducted. The study showed that dogs receiving the combination of morphine and 
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dexmedetomidine had significantly lower (p < 0.05) pain scores, obtained by the short 
form of the Glasgow composite measure pain scale and visual analogue pain scale, in 
the postoperative period. All dogs that received dexmedetomidine showed arrhythmia 
and second-degree heart block immediately after IM administration.  
Finally, the efficacy of the test drug combinations was evaluated using changes in 
electroencephalographic indices of nociception (median frequency, spectral edge 
frequency and total power) in anaesthetised dogs subjected to a noxious electrical 
stimulus. The combination of morphine and dexmedetomidine showed a significantly 
lower change in the post stimulation median and spectral edge frequencies compared to 
all other treatment groups. The dogs receiving dexmedetomidine also demonstrated 
arrhythmia and second-degree heart block.  
In conclusion, the combination of morphine and dexmedetomidine showed a superior 
analgesic effect compared to morphine alone at higher dose and appeared to be the most 
effective combination among other combinations of morphine, dexmedetomidine and 
maropitant. The cardiovascular changes produced by the test drugs may be clinically 
insignificant in fit and healthy dogs. In future, the efficacy of the combination of 
morphine, dexmedetomidine and maropitant at other different doses rates and ratios 
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